Small Pharmacies Lose Class Cert. In Caremark Antitrust Row

Law360, New York (January 19, 2017, 5:49 PM EST) -- A Pennsylvania federal district court on Wednesday denied certification to four class actions in multidistrict litigation brought by independent pharmacies who accused Caremark RX and other pharmacy benefit managers of suppressing competition by paying them less than chains for drug sales.

In a memorandum, the court denied certification to two proposed class actions, including the lead case, and decertified two others that were granted recognition before joining the MDL, rejecting the pharmacies' expert testimony and saying the claims aren't homogenous enough to proceed.

"The putative class members' disparate factual circumstances prevent the proposed national injunctive class from being sufficiently cohesive to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!